[ Price : $8.95]
A Journal of Clinical Pharmacology study finds that FDA has less oversight of overseas clinical trials that are used to form the b...[ Price : $8.95]
FDA approves a PharmaEssentia BLA for Besremi injection to treat adults with polycythemia vera, a blood disease associated with re...[ Price : $8.95]
Baxter Healthcare recalls its PrisMax System Version 2, a high permeability hemodialysis device, due to a software design error.[ Price : $8.95]
An FDA inspection of Philips Respironics results in a 29-page Form FDA-483 based on a Class 1 recall follow-up involving its conti...[ Price : $8.95]
The Oklahoma Supreme Court says a lower court erred in determining that J&J violated the states public nuisance law in the way it ...[ Price : $8.95]
FDA grants Elevar Therapeutics an orphan drug designation for rivoceranib and its use for treating hepatocellular carcinoma.[ Price : $8.95]
FDA accepts for priority review a Boehringer Ingelheim and Eli Lilly supplemental NDA for Jardiance (empagliflozin) 10 mg for redu...[ Price : $8.95]
FDA clears a Naviswiss 510(k) for its Naviplan, a digital pre-operative planning application to assist orthopedic surgeons in perf...